Legg Mason Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Legg Mason Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$903K	Sell	1,430 -71	-5%	-$43.7K	1%	30
2021 Q3	$908K	Sell	1,501 -124	-8%	-$77K	1.05%	23
2021 Q2	$908K	Sell	1,625 -145	-8%	-$73.5K	0.99%	31
2021 Q1	$837K	Buy	1,770 +304	+21%	+$148K	0.91%	37
2020 Q4	$708K	Buy	+1,466	New	+$791K	0.7%	75
2020 Q2	$812K	Hold	1,302	–	–	0.89%	41
2020 Q1	$636K	Buy	+1,302	New	+$537K	0.86%	46

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Legg Mason Asset Management's REGN Position: Q4 2021 in Review

Legg Mason Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 4.7% in Q4 2021, selling an estimated $43.7K and leaving 1,430 shares worth $903K. The position accounts for 1% of the portfolio, ranked #30.

Legg Mason Asset Management first reported a position in REGN in Q1 2020 and has held it in 7 quarters since. The position peaked at $908K in Q3 2021. 1,079 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

Legg Mason Asset Management held 1,430 shares of Regeneron Pharmaceuticals worth $903K as of Q4 2021.
Legg Mason Asset Management sold 71 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $43.7K.
Regeneron Pharmaceuticals made up 1% of Legg Mason Asset Management's portfolio in Q4 2021, its #30 holding.
Legg Mason Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 7 quarters since.
Legg Mason Asset Management's Regeneron Pharmaceuticals position peaked at $908K in Q3 2021.
1,079 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on Legg Mason Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.